| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5597879 | Annals of Vascular Surgery | 2017 | 12 Pages |
Abstract
Cirrhosis-induced plasmatic alterations may affect long-term efficacy of EVAR and should be considered when weighing endovascular treatment against open AAA repair in these high-risk patients. Surgical conversion is feasible despite the high procedural risk associated with liver disease.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Tommaso Cambiaghi, Domenico Baccellieri, Daniele Mascia, Germano Melissano, Roberto Chiesa, Andrea Kahlberg,